z-logo
Premium
The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure ( COSMIC ‐ HF )
Author(s) -
BieringSørensen Tor,
Minamisawa Masatoshi,
Liu Jiankang,
Claggett Brian,
Papolos Alexander I.,
Felker G. Michael,
McMurray John J.V.,
Legg Jason C.,
Malik Fady I.,
Honarpour Narimon,
Kurtz Christopher E.,
Teerlink John R.,
Solomon Scott D.
Publication year - 2021
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1002/ejhf.2181
Subject(s) - medicine , heart failure , cardiology , ejection fraction , pulmonary hypertension , tolerability , brain natriuretic peptide , adverse effect

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom